Advertisement

Epicardial adipose tissue thickness as an independent predictor of ventricular tachycardia recurrence following ablation

      Background

      Although several investigations have shown a relationship between increased epicardial adipose tissue (EAT) and atrial fibrillation (AF), the association between EAT and ventricular tachycardia (VT) has not been evaluated.

      Objective

      We investigated the association between EAT and postablation VT recurrence.

      Methods

      Sixty-one consecutive patients (mean age = 62.0 ± 13.9 years) undergoing VT ablation with preprocedural cardiovascular magnetic resonance imaging (CMR) were recruited. EAT thickness was measured using CMR in the right and left atrioventricular grooves (AVGs), right ventricular free wall, and anterior, inferior, and superior interventricular grooves.

      Results

      During a mean follow-up period of 392.9 ± 180.2 days, postablation VT recurrence occurred in 15 (24.6%) patients. EAT thickness was significantly higher in the VT recurrence group than in the nonrecurrent VT group at the right (18.7 ± 5.7 mm vs 14.1 ± 4.4 mm; P = .012) and left (13.3 ± 3.9 mm vs 10.4 ± 4.1 mm; P = .020) AVGs. The best cut-off points for predicting VT recurrence were calculated as 15.5 mm for the right AVG (area under receiver operating characteristic [ROC] curve = 0.74) and 11.5 mm for the left AVG (area under ROC curve = 0.72). Multivariate Cox regression analysis showed that preprocedural right AVG-EAT (hazard ratio: 1.2; 95% confidence interval: [1.06–1.39], P = .004) was the only independent predictor of VT recurrence after adjustment for covariates. Kaplan-Meier analysis showed a difference for postablation VT recurrence between the 2 groups, with right AVG-EAT thickness cut-off value of <15.5 mm vs ≥15.5 mm (log-rank, P = .003).

      Conclusions

      We suggested a new possible imaging marker for risk stratification of postablation VT recurrence. A higher EAT may be associated with VT recurrence after catheter ablation of VTs.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tilz R.R.
        • Lin T.
        • Eckardt L.
        • et al.
        Ablation outcomes and predictors of mortality following catheter ablation for ventricular tachycardia: data from the German Multicenter Ablation Registry.
        J Am Heart Assoc. 2018; 7
        • Yokokawa M.
        • Kim H.M.
        • Baser K.
        • et al.
        Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia.
        J Am Coll Cardiol. 2015; 65: 1954-1959
        • Dinov B.
        • Fiedler L.
        • Schonbauer R.
        • et al.
        Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.
        Circulation. 2014; 129: 728-736
        • Wong C.X.
        • Ganesan A.N.
        • Selvanayagam J.B.
        Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions.
        Eur Heart J. 2017; 38: 1294-1302
        • Chistiakov D.A.
        • Grechko A.V.
        • Myasoedova V.A.
        • Melnichenko A.A.
        • Orekhov A.N.
        Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology.
        Atherosclerosis. 2017; 263: 361-368
        • Okumura Y.
        Cardiac arrhythmia due to epicardial fat: is it a modifiable risk?.
        Curr Cardiovasc Risk Rep. 2017; 11: 23
        • Gaeta M.
        • Bandera F.
        • Tassinari F.
        • et al.
        Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis.
        Europace. 2017; 19: 747-752
        • Corradi D.
        • Maestri R.
        • Callegari S.
        • et al.
        The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts.
        Cardiovasc Pathol. 2004; 13: 313-316
        • Wu C.K.
        • Tsai H.Y.
        • Su M.Y.
        • et al.
        Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure.
        Atherosclerosis. 2015; 241: 607-614
        • Bertagnolli L.
        • Torri F.
        • Paetsch I.
        • et al.
        Cardiac magnetic resonance imaging for coregistration during ablation of ischemic ventricular tachycardia for identification of the critical isthmus.
        HeartRhythm Case Rep. 2018; 4: 70-72
        • Kessels K.
        • Cramer M.J.
        • Velthuis B.
        Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease.
        Heart. 2006; 92: 962
        • Liang K.-W.
        • Tsai I.-C.
        • Lee W.-J.
        • et al.
        MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome.
        Obesity. 2012; 20: 525-532
        • Ghaderi F.
        • Eshraghi A.
        • Shamloo A.S.
        • Mousavi S.
        Assosiation of epicardial and pericardial fat thickness with coronary artery disease.
        Electron Physician. 2016; 8: 2982-2989
        • Ansari M.A.
        • Mohebati M.
        • Poursadegh F.
        • Foroughian M.
        • Shamloo A.S.
        Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease? A systematic review and meta-analysis.
        Electron Physician. 2018; 10: 7249-7258
        • Sepehri Shamloo A.
        • Dagres N.
        • Dinov B.
        • et al.
        Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis.
        Int J Cardiol Heart Vasc. 2019; 22: 132-138
        • Oliver M.F.
        Sudden cardiac death: the lost fatty acid hypothesis.
        QJM. 2006; 99: 701-709
        • Kloner R.A.
        • Nesto R.W.
        Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.
        Circulation. 2008; 117: 2523-2533
        • Samanta R.
        • Pouliopoulos J.
        • Thiagalingam A.
        • Kovoor P.
        Role of adipose tissue in the pathogenesis of cardiac arrhythmias.
        Heart Rhythm. 2016; 13: 311-320
        • Kankaanpaa M.
        • Lehto H.R.
        • Parkka J.P.
        • et al.
        Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.
        J Clin Endocrinol Metab. 2006; 91: 4689-4695
        • Sasaki T.
        • Calkins H.
        • Miller C.F.
        • et al.
        New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: fat deposition after myocardial infarction on computed tomography--a pilot study.
        Heart Rhythm. 2015; 12: 1508-1518
        • Mordi I.
        • Radjenovic A.
        • Stanton T.
        • et al.
        Prevalence and prognostic significance of lipomatous metaplasia in patients with prior myocardial infarction.
        JACC Cardiovasc Imaging. 2015; 8: 1111-1112
        • Severs N.J.
        • Bruce A.F.
        • Dupont E.
        • Rothery S.
        Remodelling of gap junctions and connexin expression in diseased myocardium.
        Cardiovasc Res. 2008; 80: 9-19
        • Vignaux O.
        • Lazarus A.
        • Varin J.
        • et al.
        Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results.
        Radiology. 2002; 224: 231-235
        • Seydelmann N.
        • Wanner C.
        • Störk S.
        • Ertl G.
        • Weidemann F.
        Fabry disease and the heart.
        Best Pract Res Clin Endocrinol Metab. 2015; 29: 195-204
        • Bauer B.S.
        • Li A.
        • Bradfield J.S.
        Arrhythmogenic inflammatory cardiomyopathy: a review.
        Arrhythm Electrophysiol Rev. 2018; 7: 181-186
        • Pabon M.A.
        • Manocha K.
        • Cheung J.W.
        • Lo J.C.
        Linking arrhythmias and adipocytes: insights, mechanisms, and future directions.
        Front Physiol. 2018; 9: 1752
        • Rabkin S.W.
        • Campbell H.
        Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis.
        Obes Rev. 2015; 16: 406-415
        • Rowe M.J.
        • Neilson J.M.
        • Oliver M.F.
        Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogue.
        Lancet. 1975; 1: 295-300
        • Parisi V.
        • Petraglia L.
        • D'Esposito V.
        • et al.
        Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue.
        Int J Cardiol. 2019; 274: 326-330
        • White C.M.
        • Sander S.
        • Coleman C.I.
        • et al.
        Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
        J Am Coll Cardiol. 2007; 49: 298-303
        • Romanov A.
        • Pokushalov E.
        • Ponomarev D.
        • et al.
        Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: three-year follow-up of a randomized study.
        Heart Rhythm. 2019; 16: 172-177